Topic: Radical treatment of low- and intermediate-risk PCa
Earn accreditation points
Finish 5 cases, answer 10 questions and Earn 1 credit.
This topic consists of 5 cases
Disease Area: Prostate cancer
Background: Men with PSA-detected clinically localised PCa have excellent 10-year survival rates irrespective of the treatment (ProtecT trial). Is treatment choice here just a matter of patient preference?
Educational Objective: Gain insight into the treatment choices for men with low- and intermediate-risk PCa, with a focus on radical treatments.
Specialty: Urology, Radiation oncology
Target Audience: CME (basic), Residents (senior)
Latest update: November 1, 2018